ing. D. Oosterhuis


Postal address:
A Deusinglaan
Gebouw 3213, ruimte 0124
Phone: +31 50 363 3172Fax: +31 50 363 2500
  1. Ex Vivo Model in Cholestasis Research

    Karsten, R. E. H., Oosterhuis, D., van Wijk, L. A. & Olinga, P., 2019, Experimental Cholestasis Research. Vinken, M. (ed.). New York: Humana Press, p. 351-362 12 p. (Methods in Molecular Biology; vol. 1981).

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  2. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices

    Prins, G. H., Luangmonkong, T., Oosterhuis, D., Mutsaers, H. A. M., Dekker, F. J. & Olinga, P., 27-Feb-2019, In : Nutrients. 11, 3, 14 p., 507.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Peribiliary glands are key in regeneration of the human biliary epithelium after severe bile duct injury

    de Jong, I. E. M., Matton, A. P. M., van Praagh, J. B., van Haaften, W. T., Wiersema-Buist, J., van Wijk, L. A., Oosterhuis, D., Iswandana, R., Suriguga, S., Overi, D., Lisman, T., Carpino, G., Gouw, A. S. H., Olinga, P., Gaudio, E. & Porte, R. J., Apr-2019, In : Hepatology. 69, 4, p. 1719-1734 16 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Developing an Ex Vivo Non-Alcoholic Fatty Liver Disease Model Using Human Livers

    Prins, G., Oosterhuis, D., Van Wijk, L. A., Shelton, L. & Olinga, P., Oct-2018, In : Hepatology. 68, p. 1008A-1009A 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β

    Luangmonkong, T., Suriguga, S., Adhyatmika, A., Adlia, A., Oosterhuis, D., Suthisisang, C., de Jong, K. P., Mutsaers, H. A. M. & Olinga, P., 15-Sep-2018, In : Toxicology and Applied Pharmacology. 355, p. 127-137 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (33) »

View graph of relations

ID: 224272